The present invention relates to a kind of for providing the method for the banking of self human somatic cell, it can be reprogrammed to induced pluripotent stem cells (iPSs), transdifferentiated enters the stem cell of organizing specific, such as causes neural stem cells (iNSCs) or be divided into the cell of rear mitotic (nervous system cell system is pledged loyalty to) progenitor cells, for the processing base-material to cell therapy, the such as, but not limited to treatment of the disease of central nervous system. For providing crucial additional value for stem cell bank, the disclosure is also related to management style maintenance, such as, but it is not limited to, the source of the early stage of 20 years or more the autologous stem cells from human tissue or biofluid and its banking and manufacture, the method of the other certification of stem cell for the inclination in compliance ratifies good manufacturing practice (GMP) standard for their cell therapy manufacture and therapeutical uses in clinic. Method be applicable to using, it is by company, it is the time, suitable period offer in 20 years or more services the cell bank for being ready storage individual the stem cell of oneself, the offer of method disclosed in it adds value to identical service and to bank material by the method for reprogramming, and there is among the transdifferentation of the specific functionality in existing therapy and new therapy or the direct differentiation of stem cell are being developed it to need in the clinical test of the mankind in clinical stage or the further research of verifying by first.
